Because cancer won’t wait.
Because this fight needs the latest technology and most insightful answers. That’s why we created Oncomine Solutions, an integrated next-generation sequencing-based approach carefully designed for oncology labs—easy to implement and easy to use. Now any hospital can bring the power of Oncomine Solutions to their in-house laboratory, provide molecular insights to inform the most critical decisions, and realize the promise of precision oncology.
True precision oncology with in-house next-generation sequencing
Hear the latest about Oncomine Solutions
Webinar: NTRK Fusion Testing in Lung Cancer
View this educational webinar to learn:
- Why NTRK fusion testing is becoming important.
- Different methods of NTRK fusion detection, including their pros and cons based on real data from lung cancer testing.
- How developments in precision oncology are changing not only cancer care, but also the way we should approach biomarker testing in our laboratories.
Speaker:
PD Dr. med. Spasenija Savic Prince
Attending Pathologist
Institute for Medical Genetics and Pathology, University Hospital Basel, Switzerland
Learn More About NTRK Fusion Detection
Precision oncology
Find out why next-generation sequencing is foundational for precision oncology
Oncomine Solutions
Get an integrated next-generation sequencing solution for oncology applications
Endeavor to improve patient outcomes
Discover how NGS is driving precision oncology to improve patient outcomes
Ready to learn more?
Ask our NGS Experts any questions you might have, or subscribe to get helpful updates from our team, including white papers, webinars, videos and more!
Trademarks | Terms and Conditions | Privacy Notices
© 2019 Thermo Fisher Scientific Inc. All Rights Reserved.
Select Your Location
United Kingdom
United States